SEC Form 4 · accession 0001093557-26-000171
DEXCOM INC · DXCM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Glenn S Boehnlein
Director
Period of report
Sep 10, 2026
Accepted (ET)
Sep 10, 2026 · 4:40 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001093557
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 10, 2026 | A | 5,841 | $0.00 | A | 5,841 | D | |
| Common StockF2 | holding | — | — | — | 42 | I | By Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents a grant of restricted stock units that are exempt from Section 16b-3 and are subject to vesting in three equal annual installments from the date of grant. Restricted stock units represent a contingent right to receive one share of DexCom, Inc. Common Stock.
- F2Shares are held by the Boehnlein 2017 Trust, with respect to which the Reporting Person and the Reporting Person's spouse are co-trustees.